Abstract
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of bacterial wall molecules such as lipopolysaccharide and can therefore protect against lethal endotoxemia. Additional reported activities of LL-37 include chemoattractant function, inhibition of neutrophil apoptosis, and stimulation of angiogenesis, tissue regeneration, and cytokine release (e.g. IL-8). Cellular production of LL-37 is affected by multiple factors, including bacterial products, host cytokines, availability of oxygen, and sun exposure through the activation of CAP-18 gene expression by vitamin D3. At infection sites, the function of LL-37 can be inhibited by charge-driven interactions with DNA and F-actin released from dead neutrophils and other cells lysed as the result of inflammation. A better understanding of LL-37’s biological properties is necessary for its possible therapeutic application for immunomodulatory purposes as well as in treating bacterial infection.
Similar content being viewed by others
References
Adams JS, Liu PT, Chun R et al (2007) Vitamin D in defense of the human immune response. Ann N Y Acad Sci 1117:94–105
Andersson E, Sorensen OE, Frohm B et al (2002) Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum Reprod 17:2529–2534
Bals R, Wang X, Zasloff M et al (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 95:9541–9546
Bals R, Weiner DJ, Meegalla RL et al (1999) Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103:1113–1117
Bandholtz L, Ekman GJ, Vilhelmsson M et al (2006) Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype. Scand J Immunol 63:410–419
Barlow PG, Li Y, Wilkinson TS et al (2006) The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 80:509–520
Bergman P, Johansson L, Asp V et al (2005) Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol 7:1009–1017
Bergman P, Walter-Jallow L, Broliden K et al (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5:410–415
Berkestedt I, Nelson A, Bodelsson M (2008) Endogenous antimicrobial peptide LL-37 induces human vasodilatation. Br J Anaesth 100:803–809
Brandenburg K, Andra J, Muller M et al (2003) Physicochemical properties of bacterial glycopolymers in relation to bioactivity. Carbohydr Res 338:2477–2489
Brandenburg LO, Varoga D, Nicolaeva N et al (2008) Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis. J Neuropathol Exp Neurol 67:1041–1054
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250
Bucki R, Janmey PA (2006) Interact ion of the Gelsolin-derived antibacterial PBP10 peptides with cell membranes and lipids bilayers. Antimicrob Agents Chemother 50:2932–2940
Bucki R, Pastore JJ, Randhawa P et al (2004) Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob Agents Chemother 48:1526–1533
Bucki R, Georges PC, Espinassous Q et al (2005) Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44:9590–9597
Bucki R, Byfield FJ, Janmey PA (2007a) Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 29:624–632
Bucki R, Sostarecz AG, Byfield FJ et al (2007b) Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60:535–545
Bucki R, Byfield FJ, Kulakowska A et al (2008a) Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 181:4936–4944
Bucki R, Namiot DB, Namiot Z et al (2008b) Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 62:329–335
Carretero M, Escamez MJ, Garcia M et al (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 128:223–236
Chakraborty K, Ghosh S, Koley H et al (2008) Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol 10:2520–2537
Chamorro CI, Weber G, Gronberg A et al (2009) The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol 129:937–944
Chuang CM, Monie A, Wu A et al (2009) Treatment with LL-37 peptide enhances the antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum Gene Ther 20:303–313
Chung WO, Dommisch H, Yin L et al (2007) Expression of defensins in gingiva and their role in periodontal health and disease. Curr Pharm Des 13:3073–3083
Cinel I, Opal SM (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37:291–304
Ciornei CD, Sigurdardottir T, Schmidtchen A et al (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 49:2845–2850
Cirioni O, Giacometti A, Ghiselli R et al (2006) LL-37 protects rats against lethal sepsis caused by Gram-negative bacteria. Antimicrob Agents Chemother 50:1672–1679
Cirioni O, Ghiselli R, Tomasinsig L et al (2008) Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa. Shock 30:443–448
Coffelt SB, Scandurro AB (2008) Tumors sound the alarmin(s). Cancer Res 68:6482–6485
Coffelt SB, Waterman RS, Florez L et al (2008) Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 122:1030–1039
Conner K, Nern K, Rudisill J et al (2002) The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J Am Acad Dermatol 47:347–350
Cozzolino M, Vidal M, Arcidiacono MV et al (2003) HIV-protease inhibitors impair vitamin D bioactivation to 1, 25-dihydroxyvitamin D. AIDS 17:513–520
Davidson DJ, Currie AJ, Reid GS et al (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172:1146–1156
De Y, Chen Q, Schmidt AP et al (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069–1074
den Hertog AL, van Marle J, Veerman EC et al (2006) The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem 387:1495–1502
Frohm M, Agerberth B, Ahangari G et al (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272:15258–15263
Gaudreault E, Gosselin J (2007) Leukotriene B4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent. Viral Immunol 20:407–420
Ginsburg I (2004) Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics? it is enigmatic why this concept is consistently disregarded. Med Hypotheses 62:367–374
Hase K, Murakami M, Iimura M et al (2003) Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125:1613–1625
Heilborn JD, Nilsson MF, Jimenez CI et al (2005) Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 114:713–719
Hosaka Y, Koslowski M, Nuding S et al (2008) Antimicrobial host defense in the upper gastrointestinal tract. Eur J Gastroenterol Hepatol 20:1151–1158
Islam D, Bandholtz L, Nilsson J et al (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180–185
Johansson J, Gudmundsson GH, Rottenberg ME et al (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718–3724
Kandler K, Shaykhiev R, Kleemann P et al (2006) The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol 18:1729–1736
Kaus A, Jacobsen F, Sorkin M et al (2008) Host defence peptides in human burns. Burns 34:32–40
Khine AA, Del Sorbo L, Vaschetto R et al (2006) Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood 107:2936–2942
Kim JE, Kim BJ, Jeong MS et al (2005) Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J Korean Med Sci 20:649–654
Koczulla AR, Bals R (2003) Antimicrobial peptides: current status and therapeutic potential. Drugs 63:389–406
Koczulla R, von Degenfeld G, Kupatt C et al (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665–1672
Kumar A, Yin J, Zhang J et al (2007) Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest Ophthalmol Vis Sci 48:4664–4670
Lamb HM, Wiseman LR (1998) Pexiganan acetate. Drugs 56:1047–1052 (discussion 1053–1054)
Li X, Li Y, Han H et al (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc 128:5776–5785
Liu PT, Stenger S, Li H et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773
Lopez-Garcia B, Lee PH, Yamasaki K et al (2005) Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 125:108–115
Mallbris L, Edstrom DW, Sundblad L et al (2005) UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol 125:1072–1074
Mendez-Samperio P, Miranda E, Trejo A (2008) Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guerin. Clin Vaccine Immunol 15:1450–1455
Mookherjee N, Brown KL, Bowdish DM et al (2006a) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176:2455–2464
Mookherjee N, Wilson HL, Doria S et al (2006b) Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J Leukoc Biol 80:1563–1574
Murakami M, Ohtake T, Dorschner RA et al (2002a) Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 81:845–850
Murakami M, Ohtake T, Dorschner RA et al (2002b) Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 119:1090–1095
Nagaoka I, Hirota S, Niyonsaba F et al (2001) Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167:3329–3338
Nagaoka I, Tamura H, Hirata M (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 176:3044–3052
Nijnik A, Hancock RE (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16:41–47
Niyonsaba F, Ushio H, Nakano N et al (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127:594–604
Ooi EH, Wormald PJ, Carney AS et al (2007) Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis patients in a nasal explant model. Am J Rhinol 21:367–372
Overhage J, Campisano A, Bains M et al (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76:4176–4182
Park HJ, Cho DH, Kim HJ et al (2009) Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J Invest Dermatol 129:843–850
Peyssonnaux C, Boutin AT, Zinkernagel AS et al (2008) Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J Invest Dermatol 128:1964–1968
Pochet S, Tandel S, Querriere S et al (2006) Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Mol Pharmacol 69:2037–2046
Rivas-Santiago B, Hernandez-Pando R, Carranza C et al (2008) Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect Immun 76:935–941
Rosenfeld Y, Papo N, Shai Y (2006) Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 281:1636–1643
Schaller-Bals S, Schulze A, Bals R (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165:992–995
Shaykhiev R, Beisswenger C, Kandler K et al (2005) Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289:L842–L848
Sheils CA, Kas J, Travassos W et al (1996) Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol 148:919–927
Skokos D, Nussenzweig MC (2007) CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 204:1525–1531
Smeianov V, Scott K, Reid G (2000) Activity of cecropin P1 and FA-LL-37 against urogenital microflora. Microbes Infect 2:773–777
Tai EK, Wong HP, Lam EK et al (2008) Cathelicidin stimulates colonic mucus synthesis by up-regulating MUC1 and MUC2 expression through a mitogen-activated protein kinase pathway. J Cell Biochem 104:251–258
Tang JX, Janmey PA (1996) The polyelectrolyte nature of F-actin and the mechanism of actin bundle formation. J Biol Chem 271:8556–8563
Tang JX, Wen Q, Bennett A et al (2005) Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 289:L599–L605
Thomas-Virnig CL, Centanni JM, Johnston CE et al (2009) Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. Mol Ther 17:562–569
Tjabringa GS, Ninaber DK, Drijfhout JW et al (2006) Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol 140:103–112
Tokumaru S, Sayama K, Shirakata Y et al (2005) Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175:4662–4668
Torossian A, Gurschi E, Bals R et al (2007) Effects of the antimicrobial peptide LL-37 and hyperthermic preconditioning in septic rats. Anesthesiology 107:437–441
Travis SM, Anderson NN, Forsyth WR et al (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68:2748–2755
von Haussen J, Koczulla R, Shaykhiev R et al (2008) The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 59:12–23
Wah J, Wellek A, Frankenberger M et al (2006) Antimicrobial peptides are present in immune and host defense cells of the human respiratory and gastrointestinal tracts. Cell Tissue Res 324:449–456
Walker TS, Tomlin KL, Worthen GS et al (2005) Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73:3693–3701
Weiner DJ, Bucki R, Janmey PA (2003) The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 28:738–745
Woo JS, Jeong JY, Hwang YJ et al (2003) Expression of cathelicidin in human salivary glands. Arch Otolaryngol Head Neck Surg 129:211–214
Yoshioka M, Fukuishi N, Kubo Y et al (2008) Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol Pharm Bull 31:212–216
Yu J, Mookherjee N, Wee K et al (2007) Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol 179:7684–7691
Zasloff M (2005) Sunlight, vitamin D, and the innate immune defenses of the human skin. J Invest Dermatol 125:16–17
Zasloff M (2006) Fighting infections with vitamin D. Nat Med 12:388–390
Zhang Z, Cherryholmes G, Shively JE (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 84:780–788
Zheng Y, Niyonsaba F, Ushio H et al (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br J Dermatol 157:1124–1131
Zuyderduyn S, Ninaber DK, Hiemstra PS et al (2006) The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells. J Allergy Clin Immunol 117:1328–1335
Acknowledgments
We thank Drs. Qi Wen and Paul Janmey (University of Pennsylvania) for help with preparing AFM images and discussions and Dr. Paul Savage (Department of Chemistry and Biochemistry, Brigham Young University) for providing us with ceragenin CSA-13.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bucki, R., Leszczyńska, K., Namiot, A. et al. Cathelicidin LL-37: A Multitask Antimicrobial Peptide. Arch. Immunol. Ther. Exp. 58, 15–25 (2010). https://doi.org/10.1007/s00005-009-0057-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-009-0057-2